American Society of Hematology Partners With Major Health Organizations to Launch patientINFORM.Org
Posted on: Wednesday, 6 July 2005, 18:00 CDT
WASHINGTON, July 6, /U.S. Newswire/ -- The American Society of Hematology (ASH) is pleased to announce its participation in patientINFORM, a new online service that provides healthcare consumers with the latest research on the diagnosis and treatment of certain diseases.
patientINFORM is a partnership between three leading voluntary health organizations and a group of scholarly and medical publishers that assists patients in understanding research findings published in several peer-reviewed biomedical journals. Under the patientINFORM model, patients or their family members can visit the Web sites of the American Cancer Society ( http://www.cancer.org ), American Diabetes Association ( http://www.diabetes.org ), or American Heart Association ( http://www.americanheart.org ) to learn more about important advances in treating specific diseases. These trusted patient organizations will provide consumers with links to the full text of selected journal articles as well as interpretation of the research that patients can apply to their own healthcare needs.
Through patientINFORM, ASH is making the full text of articles in Blood, the official journal of the American Society of Hematology, available to the participating voluntary health organizations as soon as each issue is published. Consumers will be provided with direct access to Blood articles on diseases such as leukemia, lymphoma, and myeloma in a manner that helps them more fully understand the implications of the research.
During its initial pilot phase, patientINFORM will focus on cancer, diabetes, heart disease, and stroke. In the future, patientINFORM will extend its services to cover a wider range of medical conditions. Visit http://www.patientINFORM.org for more information.
---
The American Society of Hematology ( http://www.hematology.org ) is the world's largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology.
Blood, the official journal of the American Society of Hematology, is the most cited peer-reviewed publication in the field. Blood is issued to Society members and other subscribers twice per month, and is available in print and online at http:// www.bloodjournal.org .
http://www.usnewswire.com
Source: U.S. Newswire
Related Articles
- 51st Annual Meeting of the American Society of Hematology Will Highlight Research and Policy Changes Affecting Medical Practice and Patient Care
- Six Researchers to Receive Prestigious Awards from the American Society of Hematology
- 50th Annual Meeting of the American Society of Hematology Will Feature Breakthrough Research in Blood Diseases
- Three Researchers to Receive Prestigious Awards From the American Society of Hematology
- Latest Research in Blood Diseases to Be Presented at the Annual Meeting of the American Society of Hematology
- American Society of Pain Educators Releases First Ever Treatment Guidelines for Diabetic Peripheral Neuropathic Pain
- REVLIMID(R) Clinical Results As Oral Treatment Regimen in Chronic Lymphocytic Leukemia Presented at the 47th American Society of Hematology Meeting
- Studies of Nipent(R) in Combination Cancer Therapies for Treatment of Chronic Lymphocytic Leukemia and Graft-Versus Host Disease (GVHD) Presented at American Society of Hematology Annual Meeting
- 2 Americans win Nobel for chemistry research
 |
 |
User Comments (0)
RSS Feeds